Posted On: 10/26/2014 9:07:01 PM
Post# of 30066
Read into it what you would like, but there are connections...
dvanced Life Sciences - ADLS for all intense purposes dead. https://www.google.com/finance?cid=699641
Alimentary Health - Private Co. main focus probiotic healthcare and nutritional products
Historically, the business focused on Research & Development to develop novel therapeutic/ medicalised probiotic based products, for gastrointestinal health, to be licensed to large global marketing partners. One such probiotic was successfully licensed to Procter & Gamble (P&G) in 2005 and the resultant product was launched nationwide in the U.S. in 2009 and in Canada in 2012 under the brand name Align.
http://www.alimentaryhealth.ie/partners/partn...ary-health
Amylin Pharmaceuticals - The company is engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases
In June 2012, AstraZeneca and Bristol-Myers Squibb announced a two-stage deal for the joint acquisition of the biotechnology company Amylin Pharmaceuticals.[25][26] It was agreed that Bristol-Myers Squibb would acquire Amylin for $5.3 billion in cash and the assumption of $1.7 billion in debt, with AstraZeneca then paying $3.4 billion in cash to Bristol-Myers Squibb, and Amylin being folded into an existing diabetes joint-venture between AstraZeneca and Bristol-Myers Squibb.[26]
http://en.m.wikipedia.org/wiki/AstraZeneca
http://en.m.wikipedia.org/wiki/Amylin_Pharmaceuticals
Avax Technologies, Inc. hardly any news
http://www.biospace.com/News/avax-technologie...-of/323543
Only connection I could find is Shareholder meeting 2005 MEDICINOVA, INC.
Brian Anderson served as our Executive Vice President, Corporate Development from April 2004, when he joined MediciNova , to May 2005, when he was promoted to Chief Business Officer. Prior to his employment with us, he was an advisor and consultant to the investor relations firm, Montridge, LLC.
Dr. Prendergast is a co-founder and currently chairman of the board of directors of Palatin Technologies, Inc., whose shares trade on the American Stock Exchange, and AVAX Technologies, Inc., an over-the-counter traded compan
http://www.sec.gov/Archives/edgar/data/122661...def14a.htm
Avigen, Inc. - OK interesting! Brian Anderson who worked was a part of both Medicinova and Avax before MediciNova bought Avigen
MediciNova Completes Acquisition of Avigen
http://globenewswire.com/news-release/2009/12...erger.html
http://www.wikinvest.com/stock/Avigen_(AVGN)/..._of_Avigen
http://www.wikinvest.com/stock/Avigen_(AVGN)/...ockholders
dvanced Life Sciences - ADLS for all intense purposes dead. https://www.google.com/finance?cid=699641
Alimentary Health - Private Co. main focus probiotic healthcare and nutritional products
Historically, the business focused on Research & Development to develop novel therapeutic/ medicalised probiotic based products, for gastrointestinal health, to be licensed to large global marketing partners. One such probiotic was successfully licensed to Procter & Gamble (P&G) in 2005 and the resultant product was launched nationwide in the U.S. in 2009 and in Canada in 2012 under the brand name Align.
http://www.alimentaryhealth.ie/partners/partn...ary-health
Amylin Pharmaceuticals - The company is engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases
In June 2012, AstraZeneca and Bristol-Myers Squibb announced a two-stage deal for the joint acquisition of the biotechnology company Amylin Pharmaceuticals.[25][26] It was agreed that Bristol-Myers Squibb would acquire Amylin for $5.3 billion in cash and the assumption of $1.7 billion in debt, with AstraZeneca then paying $3.4 billion in cash to Bristol-Myers Squibb, and Amylin being folded into an existing diabetes joint-venture between AstraZeneca and Bristol-Myers Squibb.[26]
http://en.m.wikipedia.org/wiki/AstraZeneca
http://en.m.wikipedia.org/wiki/Amylin_Pharmaceuticals
Avax Technologies, Inc. hardly any news
http://www.biospace.com/News/avax-technologie...-of/323543
Only connection I could find is Shareholder meeting 2005 MEDICINOVA, INC.
Brian Anderson served as our Executive Vice President, Corporate Development from April 2004, when he joined MediciNova , to May 2005, when he was promoted to Chief Business Officer. Prior to his employment with us, he was an advisor and consultant to the investor relations firm, Montridge, LLC.
Dr. Prendergast is a co-founder and currently chairman of the board of directors of Palatin Technologies, Inc., whose shares trade on the American Stock Exchange, and AVAX Technologies, Inc., an over-the-counter traded compan
http://www.sec.gov/Archives/edgar/data/122661...def14a.htm
Avigen, Inc. - OK interesting! Brian Anderson who worked was a part of both Medicinova and Avax before MediciNova bought Avigen
MediciNova Completes Acquisition of Avigen
http://globenewswire.com/news-release/2009/12...erger.html
http://www.wikinvest.com/stock/Avigen_(AVGN)/..._of_Avigen
http://www.wikinvest.com/stock/Avigen_(AVGN)/...ockholders
(0)
(0)
